Bank Of America Corp Processa Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.1 - $50.0 $15 - $700	14 New	14 $0
Q1 2022 May 16, 2022	SELL	$3.01 - $5.21 $21 - $36	-7 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$4.03 - $8.42 $28 - $58	7 New	7 $0

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $18.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.